×
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.400
Biomarker
disease
BEFREE
γ-Catenin at adherens junctions: mechanism and biologic implications in hepatocellular cancer after β-catenin knockdown.
23555187 2013
×
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.400
Biomarker
disease
BEFREE
β2 spectrin-mediated differentiation repressed the properties of liver cancer stem cells through β-catenin .
29555987 2018
×
Entrez Id: 3091
Gene Symbol: HIF1A
HIF1A
0.300
Therapeutic
disease
RGD
[Prevention of hepatic tumor growth and metastasis in rats with rapamycin].
19335982 2009
×
Entrez Id: 7010
Gene Symbol: TEK
TEK
0.200
Biomarker
disease
RGD
[Expression of Ang2 and Tie2 and their relation with the angiogenesis of hepatocellular carcinoma in rats].
16951510 2006
×
Entrez Id: 2354
Gene Symbol: FOSB
FOSB
0.310
Biomarker
disease
CTD_human
[Exploration of Epigenetic Changes and DNA Methylation Markers Associated with Liver Tumors Induced by Inorganic Arsenite Exposure in Mice].
26411935 2015
×
Entrez Id: 406928
Gene Symbol: MIR137
MIR137
0.020
Biomarker
disease
BEFREE
[Corrigendum] MicroRNA-137 has a suppressive role in liver cancer via targeting EZH2.
29568886 2018
×
Entrez Id: 4087
Gene Symbol: SMAD2
SMAD2
0.220
Biomarker
disease
RGD
[Changes in TGF-beta1/Smads signaling pathway in rats with chemical hepatocarcinogenesis].
18971187 2008
×
Entrez Id: 4089
Gene Symbol: SMAD4
SMAD4
0.200
Biomarker
disease
RGD
[Changes in TGF-beta1/Smads signaling pathway in rats with chemical hepatocarcinogenesis].
18971187 2008
×
Entrez Id: 574460
Gene Symbol: MIR498
MIR498
0.010
Biomarker
disease
BEFREE
ZEB2 overexpression rescued the inhibition of liver cancer cell proliferation, migration, and invasion by miR‑498 , indicating that ZEB2 acts as a downstream effector of miR‑498 in liver cancer cells.
30592286 2019
×
Entrez Id: 9221
Gene Symbol: NOLC1
NOLC1
0.010
Biomarker
disease
BEFREE
Yet, the functioning of NOLC1 in liver cancer remains unknown.
23970161 2013
×
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.590
Biomarker
disease
BEFREE
Yet Bmi1 functions independent of Ink4A /Arf repression in liver cancer development.
19934271 2009
×
Entrez Id: 407053
Gene Symbol: MIR96
MIR96
0.200
ModifyingMutation
disease
RGD
Wnt/β-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion.
25813403 2015
×
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.400
Biomarker
disease
BEFREE
Wnt/β-catenin activation and macrophage induction during liver cancer development following steatosis.
28671671 2017
×
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.400
Biomarker
disease
BEFREE
Wnt/beta-catenin activation is observed in normal liver development, regeneration, and liver cancer .
16012954 2005
×
Entrez Id: 8644
Gene Symbol: AKR1C3
AKR1C3
0.020
AlteredExpression
disease
BEFREE
Withdrawal: "A novel AKR1C3 specific prodrug TH3424 with potent anti-tumor activity in liver cancer " Ping He, Chunnian Wang, Yanlan Wang, Caiyan Wang, Changhua Zhou, Donglin Cao, Jiang Li, David A. Bushnell, Qing Li, Roger D. Kornberg, Wei Xie, Zhong Wang.
31654399 2019
×
Entrez Id: 174
Gene Symbol: AFP
AFP
0.100
Biomarker
disease
BEFREE
With this approach, an aptamer specific to alpha-fetoprotein (AFP ), which is a biomarker for liver cancers , has been successfully selected.
22410487 2012
LGALS3BP
0.020
Biomarker
disease
BEFREE
Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts liver cancer development in chronic hepatitis B patients under antiviral treatment.
28537900 2017
LGALS3BP
0.020
Biomarker
disease
BEFREE
Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development.
27973711 2017
×
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.590
Biomarker
disease
CTD_human
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
27064257 2016
×
Entrez Id: 7015
Gene Symbol: TERT
TERT
0.560
Biomarker
disease
CTD_human
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
27064257 2016
×
Entrez Id: 324
Gene Symbol: APC
APC
0.510
Biomarker
disease
CTD_human
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
27064257 2016
×
Entrez Id: 595
Gene Symbol: CCND1
CCND1
0.390
Biomarker
disease
CTD_human
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
27064257 2016
×
Entrez Id: 378938
Gene Symbol: MALAT1
MALAT1
0.370
Biomarker
disease
CTD_human
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
27064257 2016
×
Entrez Id: 283131
Gene Symbol: NEAT1
NEAT1
0.320
Biomarker
disease
CTD_human
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
27064257 2016
×
Entrez Id: 55870
Gene Symbol: ASH1L
ASH1L
0.300
Biomarker
disease
CTD_human
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
27064257 2016